Literature DB >> 35363853

Epithelial-Mesenchymal Plasticity in Tumor Immune Evasion.

Riley D Z Mullins1,2, Ananya Pal1,2, Thomas F Barrett1,2, Molly E Heft Neal2, Sidharth V Puram1,2.   

Abstract

Epithelial-mesenchymal transition (EMT) is a fundamental process that occurs during embryogenesis and tissue repair. However, EMT can be hijacked by malignant cells, where it may promote immune evasion and metastasis. Classically considered a dichotomous transition, EMT in cancer has recently been considered a plastic process whereby malignant cells display and interconvert among hybrid epithelial/mesenchymal (E/M) states. Epithelial-mesenchymal plasticity (EMP) and associated hybrid E/M states are divergent from classical EMT, with unique immunomodulatory effects. Here, we review recent insights into the EMP-immune cross-talk, highlighting possible mechanisms of immune evasion conferred by hybrid E/M states and roles of immune cells in EMP. ©2022 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35363853      PMCID: PMC9256788          DOI: 10.1158/0008-5472.CAN-21-4370

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   13.312


  181 in total

1.  Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1.

Authors:  Oscar H Ocaña; Rebeca Córcoles; Angels Fabra; Gema Moreno-Bueno; Hervé Acloque; Sonia Vega; Alejandro Barrallo-Gimeno; Amparo Cano; M Angela Nieto
Journal:  Cancer Cell       Date:  2012-11-29       Impact factor: 31.743

2.  IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells.

Authors:  Romaine I Fernando; Marianne D Castillo; Mary Litzinger; Duane H Hamilton; Claudia Palena
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

3.  Co-expression of cytokeratin and vimentin in colorectal cancer highlights a subset of tumor buds and an atypical cancer-associated stroma.

Authors:  Sara N Meyer; José A Galván; Stefan Zahnd; Lena Sokol; Heather Dawson; Alessandro Lugli; Inti Zlobec
Journal:  Hum Pathol       Date:  2019-02-20       Impact factor: 3.466

4.  The epithelial-mesenchymal transition generates cells with properties of stem cells.

Authors:  Sendurai A Mani; Wenjun Guo; Mai-Jing Liao; Elinor Ng Eaton; Ayyakkannu Ayyanan; Alicia Y Zhou; Mary Brooks; Ferenc Reinhard; Cheng Cheng Zhang; Michail Shipitsin; Lauren L Campbell; Kornelia Polyak; Cathrin Brisken; Jing Yang; Robert A Weinberg
Journal:  Cell       Date:  2008-05-16       Impact factor: 41.582

Review 5.  Contextual determinants of TGFβ action in development, immunity and cancer.

Authors:  Charles J David; Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2018-07       Impact factor: 94.444

Review 6.  Measuring and Modelling the Epithelial- Mesenchymal Hybrid State in Cancer: Clinical Implications.

Authors:  Mohit Kumar Jolly; Ryan J Murphy; Sugandha Bhatia; Holly J Whitfield; Andrew Redfern; Melissa J Davis; Erik W Thompson
Journal:  Cells Tissues Organs       Date:  2021-04-26       Impact factor: 2.481

7.  TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.

Authors:  Sanjeev Mariathasan; Shannon J Turley; Dorothee Nickles; Alessandra Castiglioni; Kobe Yuen; Yulei Wang; Edward E Kadel; Hartmut Koeppen; Jillian L Astarita; Rafael Cubas; Suchit Jhunjhunwala; Romain Banchereau; Yagai Yang; Yinghui Guan; Cecile Chalouni; James Ziai; Yasin Şenbabaoğlu; Stephen Santoro; Daniel Sheinson; Jeffrey Hung; Jennifer M Giltnane; Andrew A Pierce; Kathryn Mesh; Steve Lianoglou; Johannes Riegler; Richard A D Carano; Pontus Eriksson; Mattias Höglund; Loan Somarriba; Daniel L Halligan; Michiel S van der Heijden; Yohann Loriot; Jonathan E Rosenberg; Lawrence Fong; Ira Mellman; Daniel S Chen; Marjorie Green; Christina Derleth; Gregg D Fine; Priti S Hegde; Richard Bourgon; Thomas Powles
Journal:  Nature       Date:  2018-02-14       Impact factor: 49.962

Review 8.  TRAIL receptor-induced features of epithelial-to-mesenchymal transition increase tumour phenotypic heterogeneity: potential cell survival mechanisms.

Authors:  Ludovic Peyre; Mickael Meyer; Paul Hofman; Jérémie Roux
Journal:  Br J Cancer       Date:  2020-12-01       Impact factor: 7.640

9.  Transcriptional census of epithelial-mesenchymal plasticity in cancer.

Authors:  David P Cook; Barbara C Vanderhyden
Journal:  Sci Adv       Date:  2022-01-05       Impact factor: 14.136

10.  Immunoproteasome expression is associated with better prognosis and response to checkpoint therapies in melanoma.

Authors:  Shelly Kalaora; Joo Sang Lee; Eilon Barnea; Ronen Levy; Polina Greenberg; Michal Alon; Gal Yagel; Gitit Bar Eli; Roni Oren; Aviyah Peri; Sushant Patkar; Lital Bitton; Steven A Rosenberg; Michal Lotem; Yishai Levin; Arie Admon; Eytan Ruppin; Yardena Samuels
Journal:  Nat Commun       Date:  2020-02-14       Impact factor: 14.919

View more
  1 in total

1.  A transcriptomic map of EGFR-induced epithelial-to-mesenchymal transition identifies prognostic and therapeutic targets for head and neck cancer.

Authors:  Henrik Schinke; Enxian Shi; Zhongyang Lin; Tanja Quadt; Gisela Kranz; Jiefu Zhou; Hongxia Wang; Julia Hess; Steffen Heuer; Claus Belka; Horst Zitzelsberger; Udo Schumacher; Sandra Genduso; Kristoffer Riecken; Yujing Gao; Zhengquan Wu; Christoph A Reichel; Christoph Walz; Martin Canis; Kristian Unger; Philipp Baumeister; Min Pan; Olivier Gires
Journal:  Mol Cancer       Date:  2022-09-08       Impact factor: 41.444

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.